Title: New Heart Attack Emergency Drug
Author: Wáng Guóruì
Date: 1989-05-20
Page: 3

Xinhua News Agency, London, May 19th

New Heart Attack Emergency Drug

The British Ministry of Health has approved the use of a new drug that dissolves blood clots for the emergency treatment of heart attack patients.

This drug, called Eminaise, has been tested on over 1,000 patients and has shown to reduce the mortality rate of heart attack patients by approximately 50%.

The main advantages of this drug are: it can be administered intravenously on the spot, with the injection taking only 5 minutes; after injection, blood clots dissolve quickly; the effect of dissolving blood clots lasts for several hours, preventing the formation of new blood clots.

Other two heart attack emergency drugs require the patient to be taken to the hospital for intravenous treatment. Only 30% of heart attack patients are taken to the hospital within 4 hours, and the delay increases the risk of death.

In Britain, there are 230,000 heart attack patients each year, of whom 160,000 die.

Eminaise was invented by the Beecham Pharmaceutical Company in Surrey, England. This drug is a bacterial protein, produced using chemical synthesis and biotechnology.

Currently, 11 European countries are conducting clinical trials on Eminaise.


<hr /> 

Original: 


### 新的心脏病急救药
王国瑞
1989-05-20
第3版(国际新闻)
专栏：

　　新的心脏病急救药
    新华社伦敦５月１９日电  （记者王国瑞）英国卫生部已经批准使用一种新的溶解血栓的药，用于抢救心脏病发作病人的生命。
    这种药名叫埃米纳塞。对１０００多名病人的试验证明，它使心脏病发作病人的死亡率减少大约５０％。
    这种药的主要优点是：能够就地静脉注射，注射时间只需５分钟；注射后，血栓很快溶解；溶解血栓的作用持续数小时，防止形成新的血栓。
    而其他两种心脏病急救药则要求把病人送到医院才能做输液。心脏病发作４小时内送入医院的只占３０％，时间上的拖延增加了病人死亡的危险性。
    英国每年有２３万心脏病发作病人，其中１６万人死亡。
    埃米纳塞是英国萨里郡比查姆制药公司发明的，这种药是一种细菌蛋白，用化学合成和生物技术制造。
    现在，１１个欧洲国家正在对埃米纳塞作临床试验。　
